On Friday, Shares of The Coca-Cola Co (NYSE:KO), gained 1.23% to $39.63.
The Coca-Cola will sell nine bottling plants to three independent bottlers, counting two facilities in Maryland and one in Virginia, according to Business Journals.
Coca-Cola Bottling Co. Merged will acquire production facilities in Sandston, Virginia, Baltimore and Silver Spring.
Coca-Cola did not right away respond to an email request for number of employees in Maryland and Virginia influenced, or their future employment status.
Other facilities, in Indianapolis, Portland, Indiana, Cincinnati, New Orleans, Phoenix and Denver will be attained by Merged, Coca-Cola Bottling Company United, and Swire Coca-Cola USA. Business Journals Reports
The Coca-Cola Company is a beverage company. The Company owns or licenses and markets more than 500 nonalcoholic beverage brands, primarily sparkling beverages but also a range of still beverages, such as waters, enhanced waters, juices and juice drinks, ready-to-drink teas and coffees, and energy and sports drinks.
Shares of EMC Corporation(NYSE:EMC), inclined 0.08% to $23.78, during its last trading session.
EMC Corporation declared three organizations as grant recipients of the 2015 EMC Heritage Trust Project. The grants will support projects that practice and encourage the stewardship of cultural information in local communities in Canada, Colombia and the Philippines.
EMC Corporation (EMC) is a service provider to information technology (IT) operations to an as a service model (ITaaS). It develops, delivers and supports the IT industry’s range of information infrastructure and virtual infrastructure technologies, solutions and services. EMC manages the Company as part of a federation of businesses: EMC Information Infrastructure, VMware Virtual Infrastructure and Pivotal.
Shares of MGM Resorts International (NYSE:MGM), inclined 1.07% to $19.76, during its last trading session.
MGM Resorts International - Tatsuo Miyajima, one of Japan’s most influential artists over the past two decades, debuted his work “HOTO” (2008) in the United States for the first time this week for an indefinite engagement at The Shops at Crystals in Las Vegas. The piece formerly has been on display only in Japan and China.
Inspired by Buddhist scripture, HOTO – meaning “treasure pagoda” – refers to a story about a monumental bejeweled tower that emerges from the ground, floats midair and covers half the world, symbolizing the importance of every human life. According to Buddhist teachings, life cannot be described without such an impossible story because life is nothing but a miracle.
It was this scripture and the devastating events of September 11, 2001 that inspired Miyajima to create HOTO, which represents his belief that every life is important in addition to his hope for inter-connectedness across the globe creating peace and community.
To share his message, Miyajima – recognized for work that merges a philosophical appreciation of life with the latest technologies – created a remarkable mirrored pagoda measuring 18 feet high and more than six feet around, inlaid with 3,827 vibrantly colored LED numerical displays in varying sizes. The LED displays flash the numbers nine through one in a descending, continuous series and at varying speeds, representing the never-ending cycle of life, the universal language of numbers and how every life moves at its own unique pace.
MGM Resorts International is a holding company. Through its wholly owned subsidiaries, the Company owns and operates casino resorts. The Company operates in two segments: wholly owned domestic resorts and MGM China. The wholly owned domestic resorts segment includes non-gaming operations, including hotel, food and beverage, entertainment and other non-gaming amenities.
Finally, Arrowhead Research Corp (NASDAQ:ARWR), ended its last trade with 0.97% gain, and closed at $7.26.
Arrowhead Research Corp is one step closer to achieving a cure for hepatitis B infection, Chief Executive Christopher Anzalone said.
The drug developer’s stock jumped 18 percent in afternoon trading on Thursday, after the company presented positive data on its experimental antiviral therapy, according to Reuters.
The virus is 100 times more infectious than HIV, but can be prevented with a vaccine that has been available since 1982.
However, for the 400 million people worldwide who are already chronically infected with hepatitis B, the vaccine is ineffective.
Existing hepatitis B drugs do not completely cure the infection in many cases, but tend to suppress viral replication, forcing patients to continue taking them for life.
Arrowhead’s drug, ARC-520, knocked down various hep B viral components, reducing one of the key disease-causing proteins of the virus by more than 90 percent in formerly treated and untreated patients, data showed. Reuters Reports
Arrowhead Research Corporation develops drugs to treat intractable diseases by silencing the genes that cause them. Using the broadest portfolio of RNA chemistries and efficient modes of delivery, the Company’s therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
